Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity. [PDF]
Chen WH +44 more
europepmc +1 more source
CHOサイボウヲモチイタナンハツゲンサメIgNARコウタイセイサン:ボトルネックノカイメイトセイサンセイカイゼンノココロミ [PDF]
Lyu, Xiaofang +2 more
core +1 more source
Structural and functional evolution of IL-1 targeting: From systemic neutralization to bioengineered nanotherapies. [PDF]
Yang L, Chen G, Lyu Z.
europepmc +1 more source
Characteristics and Genomic Localization of Nurse Shark (Ginglymostoma cirratum) IgNAR. [PDF]
Tang W +12 more
europepmc +1 more source
Nanobody-enhanced chimeric antigen receptor T-cell therapy: overcoming barriers in solid tumors with VHH and VNAR-based constructs. [PDF]
Guo S, Xi X.
europepmc +1 more source
A shark-derived broadly neutralizing nanobody targeting a highly conserved epitope on the S2 domain of sarbecoviruses. [PDF]
Feng B +15 more
europepmc +1 more source
Unusual traits shape the architecture of the Ig ancestor molecule. [PDF]
Urdiciain A +6 more
europepmc +1 more source
A Single-Domain VNAR Nanobody Binds with High-Affinity and Selectivity to the Heparin Pentasaccharide Fondaparinux. [PDF]
Gschwandtner M +11 more
europepmc +1 more source
Identification and transcriptional characterisation of novel inhibitors of NAV1.7 AND TRKB [PDF]
Hompoonsup, Supanida
core
Isolation and Characterization of the First Antigen-Specific EGFRvIII vNAR from Freshwater Stingray (<i>Potamotrygon</i> spp.) as a Drug Carrier in Glioblastoma Cancer Cells. [PDF]
Manzanares-Guzmán A +7 more
europepmc +1 more source

